Molecular Analysis of GALT Gene in Cuban Patients with Classical Galactosemia
Keywords:
galactose-1-phosphate uridyltransferase deficiency disease, allele frequency, genetic heterogeneity, mutation.Abstract
Introduction: Classical galactosemia is the most severe and prevalent genetic disorder of galactose metabolism worldwide. It is caused by mutations in GALT gene, in which more than 300 allelic variants have been identified. No molecular studies have been performed in Cuba to identify the mutations present in patients. Objective: To identify allelic variants of GALT gene in Cuban patients with classical galactosemia. Methods: Genomic DNA was isolated from 29 patients by the salt precipitation method. Six mutations were detected by polymerase chain reaction-enzymatic digestion-electrophoresis. GALT gene sequencing was performed on ten samples. Results: The mutations p.Q188R, p.L195P, p.S135L, p.N314D and p.L218L were detected by polymerase chain reaction-enzymatic digestion-electrophoresis. In addition, six mutations were identified by sequencing, three in the exonic region: p.F171S, p.T292T and p.H315H; and three in the intronic region: c.378-27G>C, c.507+62G>A and c.508-24G>A. Conclusions: The mutations found show the allelic genetic heterogeneity of classical galactosemia in the Cuban population. This knowledge can contribute to improving prenatal and postnatal molecular diagnosis, the study of carriers, and genetic counseling of patients and family members.Downloads
References
1. Berry GT. Classic Galactosemia and Clinical Variant Galactosemia. En: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Ameniya A, editores. GeneReviews. Seattle: Universidad de Washington; 1993 [acceso 17/05/2021]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK1518/
2. Rossi-Espagnet MC, Sudhakar S, Fontana E, Longo D, Davison J, Petengill AL, et al. Neuroradiologic Phenotyping of Galactosemia: From the Neonatal Form to the Chronic Stage. Am J Neuroradiol. 2021;42(3):590-6. DOI: https://doi.org/10.3174/ajnr.A7016
3. Rubio-Gozalbo ME, Haskovic M, Bosch AM, Burnyte B, Coelho AI, Cassiman D, et al. The natural history of classic galactosemia: lessons from the GalNet registry. Orphanet J Rare Dis. 2019;14(1). DOI: https://doi.org/10.1186/s13023-019-1047-z
4. Welsink-Karssies MM, Ferdinandusse S, Geurtsen GJ, Hollak CEM, Huidekoper HH, Janssen MCH, et al. Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers. Brain Commun. 2020;2(1). DOI: https://doi.org/10.1093/braincomms/fcaa006
5. Kuiper A, Grunewald S, Murphy E, Coenen MA, Eggink H, Zutt R, et al. Movement disorders and nonmotor neuropsychological symptoms in children and adults with classical galactosemia. J Inherit Metab Dis. 2019;42(3):451-8. DOI: https://doi.org/10.1002/jimd.12054
6. Korner M, Kalin S, Zweifel-Zehnder A, Fankhauser N, Nuoffer JM, Gautschi M. Deficits of facial emotion recognition and visual information processing in adult patients with classical galactosemia. Orphanet J Rare Dis. 2019;14(1). DOI: https://doi.org/10.1186/s13023-019-0999-3
7. Calderon FR, Phansalkar AR, Crockett DK, Miller M, Mao R. Mutation database for the galactose-1-phosphate uridyltransferase (GALT) gene. Hum Mutat. 2007;28(10):939-43. DOI: https://doi.org/10.1002/humu.20544
8. Landrum MJ, Kattman BL. ClinVar at five years: Delivering on the promise. Hum Mutat. 2018;39(11):1623-30. DOI: https://doi.org/10.1002/humu.23641
9. Gort L, Boleda MD, Tyfield L, Vilarinho L, Rivera I, Cardoso ML, et al. Mutational spectrum of classical galactosaemia in Spain and Portugal. J Inherit Metab Dis. 2006;29(6):739-42. DOI: https://doi.org/10.1007/s10545-006-0356-2
10. Lai K, Langley SD, Singh RH, Dembure PP, Hjelm LN, Elsas LJ. A prevalent mutation for galactosemia among black Americans. J Pediatr. 1996;128(1):89-95. DOI: https://doi.org/10.1016/s0022-3476(96)70432-8
11. Suzuki M, West C, Beutler E. Large-scale molecular screening for galactosemia alleles in a pan-ethnic population. Hum Genet. 2001;109:210-5. DOI: https://doi.org/10.1007/s004390100552
12. Fridovich-Keil JL, Carlock G, Coles CD, Lynch ME, Millians MN, Potter NL, et al. Developmental outcomes of children with Duarte galactosemia: exploring the bases of an apparent contradiction in the literature. Genet Med. 2019;21(12):2683-5. DOI: https://doi.org/10.1038/s41436-019-0567-1
13. Carlock G, Fischer ST, Lynch ME, Potter NL, Coles CD, Epstein MP, et al. Developmental Outcomes in Duarte Galactosemia. Pediatrics. 2019;143(1). DOI: https://doi.org/10.1542/peds.2018-2516
14. González-Reyes EC, Castells EM, Frómeta A, Arteaga AL, Río LD, Tejeda Y, et al. SUMA Technology and Newborn Screening Tests for Inherited Metabolic Diseases in Cuba: An Overview of the First 30 Years. Journal of Inborn Errors of Metabolism and Screening. 2016;4:1-9. DOI: https://doi.org/10.1177/2326409816661356
15. Kozak L, Francova H, Fajkusova L, Pijackova A, Macku J, Stastna S, et al. Mutation analysis of the GALT gene in Czech and Slovak galactosemia populations: identification of six novel mutations, including a stop codon mutation (X380R). Hum Mutat. 2000;15(2). DOI: https://doi.org/10.1002/(SICI)1098-1004(200002)15:2<206::AID-HUMU13>3.0.CO;2-O
16. Garcia DF, Camelo JS, Molfetta GA, Turcato M, Souza CF, Porta G, et al. Clinical profile and molecular characterization of Galactosemia in Brazil: identification of seven novel mutations. BMC Med Genet. 2016;17(1). DOI: https://doi.org/10.1186/s12881-016-0300-8
17. Crespo C, Eiroa H, Otegui MI, Bonetto MC, Chertkoff L, Gravina LP. Molecular analysis of GALT gene in Argentinian population: Correlation with enzyme activity and characterization of a novel Duarte-like allele. Mol Genet Metab Rep. 2020;25. DOI: https://doi.org/10.1016/j.ymgmr.2020.100695
18. Jezela-Stanek A, Bauer A, Wertheim-Tysarowska K, Bal J, Rygiel AM, Sykut-Cegielska J. The genetic basis of classical galactosaemia in Polish patients. Orphanet J Rare Dis. 2021;16(1). DOI: https://doi.org/10.1186/s13023-021-01869-3
19. Wang BB, Xu YK, Ng WG, Wong LJ. Molecular and biochemical basis of galactosemia. Mol Genet Metab. 1998;63(4):263-9. DOI: https://doi.org/10.1006/mgme.1998.2678
20. Ozgul RK, Guzel-Ozanturk A, Dundar H, Yucel-Yilmaz D, Coskun T, Sivri S, et al. Galactosemia in the Turkish population with a high frequency of Q188R mutation and distribution of Duarte-1 and Duarte-2 variations. J Hum Genet. 2013;58(10):675-8. DOI: https://doi.org/10.1038/jhg.2013.76
21. Hirokawa H, Okano Y, Asada M, Fujimoto A, Suyama I, Isshiki G. Molecular basis for phenotypic heterogeneity in galactosaemia: prediction of clinical phenotype from genotype in Japanese patients. Eur J Hum Genet. 1999;7(7):757-64. DOI: https://doi.org/10.1038/sj.ejhg.5200368
22. Estrada SC, Canson DM, Silao CL. Mutational analysis of the GALT gene in Filipino patients. Kobe J Med Sci. 2013 [acceso 12/09/2019];59(3). Disponible en: https://www.med.kobe-u.ac.jp/journal/contents/59/E106.pdf
23. Ohlsson A, Hunt M, Wedell A, von Dobeln U. Heterogeneity of disease-causing variants in the Swedish galactosaemia population: Identification of 16 novel GALT variants. J Inherit Metab Dis. 2019;42(5). DOI: https://doi.org/10.1002/jimd.12136
24. Yuzyuk T, Viau K, Andrews A, Pasquali M, Longo N. Biochemical changes and clinical outcomes in 34 patients with classic galactosemia. J Inherit Metab Dis. 2018;19(10):18-136. DOI: https://doi.org/10.1007/s10545-018-0136-9
25. Papachristoforou R, Petrou PP, Sawyer H, Williams M, Drousiotou A. Classic galactosaemia in the Greek Cypriot population: An epidemiological and molecular study. Ann Hum Genet. 2019;83(5);291-8. DOI: https://doi.org/10.1111/ahg.12318
26. Coffee B, Hjelm LN, DeLorenzo A, Courtney EM, Yu C, Muralidharan K. Characterization of an unusual deletion of the galactose-1-phosphate uridyl transferase (GALT) gene. Genet Med. 2006;8(10):635-40. DOI: https://doi.org/10.109701.gim.0000237720.78475.fb
27. Gonzalez A, Velazquez J, Alcantara MA, Vela M, Hernandez N. Phenotype-Genotype Discrepancy Due to a 5.5-kb Deletion in the GALT Gene. JIMD Rep. 2012;2:1-5. DOI: https://doi.org/10.1007/8904_2011_30
28. Schulpis KH, Thodi G, Chatzidaki M, Iakovou K, Molou E, Dotsikas Y, et al. Rare cases of galactose metabolic disorders: identification of more than two mutations per patient. J Pediatr Endocrinol Metab. 2017;30(10):1119-20. DOI: https://doi.org/10.1515/jpem-2017-0263
29. Schulpis KH, Thodi G, Iakovou K, Dotsikas Y, Molou E, Loukas YL. Identification of five mutations in a patient with galactose metabolic disorders. J Pediatr Endocrinol Metab. 2018;31(2):221-2. DOI: https://doi.org/10.1515/jpem-2017-0438
Downloads
Published
How to Cite
Issue
Section
License
Avisos de derechos de autor propuestos por Creative Commons
1. Política propuesta para revistas que ofrecen acceso abierto
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores/as conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores/as podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un archivo telemático institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores/as difundir su obra a través de Internet (p. ej.: en archivos telemáticos institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto).
